X-150987913-AAAG-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP6BS2
The NM_005342.4(HMGB3):c.*2_*4delGAA variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.00000588 in 1,190,552 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.0000090 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.0000056 ( 0 hom. 3 hem. )
Consequence
HMGB3
NM_005342.4 3_prime_UTR
NM_005342.4 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.56
Genes affected
HMGB3 (HGNC:5004): (high mobility group box 3) This gene encodes a member of a family of proteins containing one or more high mobility group DNA-binding motifs. The encoded protein plays an important role in maintaining stem cell populations, and may be aberrantly expressed in tumor cells. A mutation in this gene was associated with microphthalmia, syndromic 13. There are numerous pseudogenes of this gene on multiple chromosomes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP6
Variant X-150987913-AAAG-A is Benign according to our data. Variant chrX-150987913-AAAG-A is described in ClinVar as [Likely_benign]. Clinvar id is 3030198.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAdExome4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGB3 | NM_005342.4 | c.*2_*4delGAA | 3_prime_UTR_variant | 5/5 | ENST00000325307.12 | NP_005333.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMGB3 | ENST00000325307.12 | c.*2_*4delGAA | 3_prime_UTR_variant | 5/5 | 1 | NM_005342.4 | ENSP00000359393.3 | |||
HMGB3 | ENST00000448905.6 | c.*2_*4delGAA | 3_prime_UTR_variant | 5/5 | 1 | ENSP00000442758.1 | ||||
HMGB3 | ENST00000455596.5 | c.*22_*24delAAG | downstream_gene_variant | 1 | ENSP00000405601.1 | |||||
HMGB3 | ENST00000419110.5 | c.*37_*39delAAG | downstream_gene_variant | 3 | ENSP00000410354.1 |
Frequencies
GnomAD3 genomes AF: 0.00000896 AC: 1AN: 111565Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33731
GnomAD3 genomes
AF:
AC:
1
AN:
111565
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33731
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 2AN: 166913Hom.: 0 AF XY: 0.0000171 AC XY: 1AN XY: 58559
GnomAD3 exomes
AF:
AC:
2
AN:
166913
Hom.:
AF XY:
AC XY:
1
AN XY:
58559
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000556 AC: 6AN: 1078987Hom.: 0 AF XY: 0.00000851 AC XY: 3AN XY: 352455
GnomAD4 exome
AF:
AC:
6
AN:
1078987
Hom.:
AF XY:
AC XY:
3
AN XY:
352455
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000896 AC: 1AN: 111565Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33731
GnomAD4 genome
AF:
AC:
1
AN:
111565
Hom.:
Cov.:
22
AF XY:
AC XY:
0
AN XY:
33731
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
HMGB3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 01, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at